The growth of human leukemic cells in culture and in vivo is dependent upon 
Introduction
The growth of human acute myeloblastic leukemia (AML)' cells in culture and in vivo is dependent upon the presence of growth factors. The requirement for growth factors in culture has been demonstrated by colony forming assays in which the growth of the cells is usually dependent upon the addition of a variety of growth factors (1-3); these include granulocytemacrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF), IL-3, and kit ligand (KL) 1 . Abbreviations used in this paper: AML, acute myeloblastic leukemia; FMS, CSF-I receptor; KL, kit ligand; MGF, must cell growth factor; mIL-3, murine IL-3; mKit, murine c-Kit; SCF, stem cell factor.
(also referred to as mast cell growth factor [MGF] [4] , or stem cell factor [SCF] [5] ). Other factors such as IL-1 and IL-6 synergize with the above factors to enhance colony formation (3, 6, 7) . Though colony formation may occur in the absence of added growth factor(s), these cells rarely continue to grow for long periods of time. Moreover, in many cases of factor independent growth, the leukemic cells are producing their own growth factors (8) . It has been suggested that leukemic cells are dependent on growth factors in vivo, based on the dependence on growth factors in culture (3, 9) . The important growth factor-growth factor receptor pairs that operate in vivo in leukemia have not been identified; c-Kit and its ligand have characteristics that make them prime candidates for such a pair.
The c-Kit protein is a transmembrane tyrosine kinase receptor that is similar in structure to the CSF-1 receptor (FMS), the PDGF receptor and the flk-2/flt3 receptor (10) (11) (12) . c-Kit is expressed by early haematopoietic cells (13) . Naturally occurring mutations of c-Kit in mice lead to the W phenotype characterized in part by a macrocytic anemia and a reduced number of CFU-S (14, 15) . The ligand for c-Kit has been cloned and studied. The Kit ligand (KL) protein is expressed either as a membrane bound form that can be cleaved to give a soluble product, or as a membrane bound form that remains on the cell surface (4, 16, 17) . The protein is constitutively expressed by a variety of tissues including bone marrow stromal cells, liver, lung, kidney, brain, and gut (18) (19) (20) . Mutations of KL result in the Steel phenotype that is grossly indistinguishable from mice carrying W mutations.
A role for c-Kit and KL in leukemogenesis was suggested initially by the observation that c-Kit mRNA and protein are expressed by leukaemic cells in most cases of AML (21) (22) (23) . There is both patient to patient and cell to cell variation in the level of expression of c-Kit on the surface of leukemic cells. More recent studies have shown that in tissue culture KL will support the clonal growth and self renewal capacity of colony forming cells (24) . The persistent expression of c-Kit by leukaemic cells and the fact that KL is expressed at a relatively high level by normal tissues raises the possibility that the interaction between Kit and its ligand may be important in the development or maintenance of the leukaemic state. To investigate this in a model system we have introduced a murine c-Kit (mKit) cDNA into 32D cells, a nonleukemogenic factor-dependent murine cell line (25) . These cells become dependent on KL for survival and growth and can lead to the development of leukaemia in syngeneic animals.
Methods
Cell lines. The cell line used in this study, 32D, was established from normal C3H/HeJ mouse bone marrow by the infection with the Friend murine leukaemia virus (25) . The cells were maintained in a-medium, 10% fetal calf serum (FCS) and 10 U/ml of murine IL-3 (mIL-3). The mIL-3 was used as a crude conditioned medium of a myeloma cell line X63Ag8-653 engineered to express mIL-3 (26) . SI/ S14, a stromal cell line derived from S 1/SI fetal liver, was obtained from Dr. David Williams and maintained in a-medium and 10% FCS (27) . Sl0 bone marrow stromal cells were obtained from Dr. K. Dorshkind and maintained in a-medium and 10% FCS (28) .
Vectors. A cDNA of mKit lacking the amino acids GNNK just 5' of the transmembrane region (29, 30) and with a truncation of 3' nonencoding sequences was cloned into the XhoI-NotI sites of the retrovirus LXSNnot, resulting in LXSNnot-mKit (30) . LXSNnot was derived from LXSN by introducing a NotI site just 3' of the BamH I site (31 ) .
The virus encodes a neo gene that allows for selection of cells infected with the virus by growth in G418.
Creation of mKit expressing and neo resistant cell lines. The cell line 32mKit(A4) was created at Immunex in Seattle as follows. LXSNnot-mKit plasmid was transfected into the ecotropic PG+86E packaging cell line and a G418 resistant clone expressing a high titre of virus selected. Supernatant containing virus was used to infect 32D cells and G418-resistant clones were selected. One of the clones (A4) which expressed mKit was selected for further study. The K series of Kit expressing 32D cell lines was created at the Ontario Cancer Institute. LXSNnot-mKit was introduced into 32D cells by electroporation (1,000 V and 25 jIF) (32) and mKit expressing cells were selected for by exposing the cells to 200 ng/ml of murine KL(mKL) in the absence of IL-3.
A control population of 32 D cells expressing neo, named 32Dneo, was created by electroporating the cells in the presence of retrovirus plasmid pBabe-neo and then selecting for resistant cells with 1 mg/ml of G418 (33) .
Northern blot analysis. Northern blot analysis was carried out as previously described (34 (38) and mKL was purified by affinity chromatography with rabbit anti-mKL polyclonal antibodies (S. A. Berger, unpublished) immobilized on CnBr-activated Sepharose (Sigma Chemical Co., St. Louis, MO).
Murine KL was conjugated with biotin using the method described by Goding (39). Affinity purified protein was dialysed against 0.1 M NaHCO3, pH 8.2. 60 pl of biotin-succinimide ester (Calbiochem Corp., La Jolla, CA), freshly dissolved in DMSO to a concentration of 2 mg/ ml was added to 0.5 ml of purified mKL (140 jig/ml) and incubated at room temperature for 3 h. The sample was then dialyzed extensively against phosphate buffered saline/0.1% sodium azide. The sample was collected and bovine serum albumin (Boehringer Mannheim, Indianapolis, IN), was added as carrier to a final concentration of 1 mg/ml. The biotinylated protein retained almost full activity as determined by stimulation of murine MC-9 mast cells as measured by 3HTdR incorporation. In a 2-d assay the D50 of the biotinylated protein (assuming no loss during dialysis) was 218 ng/ml. In the same assay the DM of unconjugated protein was 150 ng/ml.
The degree of conjugation was determined by competition for biotinylated-mKL bioactivity by streptavidin. The addition of streptavidin competed for KL activity in a dose dependent manner. The addition of 3 jig/mI of streptavidin completely eliminated stimulating activity of the conjugated KL without affecting the activity of unconjugated protein.
The results indicate that the protein preparation was fully conjugated.
Cell surface Kit expression. To measure the cell surface expression of Kit, 1 x 106 cells in a minimum volume (10 jd) of balanced salt solution containing 5% newborn calf serum (BSS/5% NBS) were incubated with biotinylated mKL (140 ,ug/ml) at a dilution of 1:10 for 1 h on ice. After two washes in BSS/5% NBS the cells were incubated on ice with a 1:100 dilution of streptavidin-phycoerythrin (Southern Biotechnology) in BSS/5%NBS for 20 min. The cells were then washed and analyzed. To further confirm Kit protein on the cell surface, ACK-2, a monoclonal anti-mKit antibody (kindly provided by Dr. S. Nishikawa) was used to label cells (40) . Briefly, 1 x 106 cells were incubated with the ACK-2 antibody at a concentration known to give maximum staining, in BSS/5% NBS for 20 min on ice. After two washes in BSS/ 5% NBS the cells were incubated in FITC-conjugated mouse anti-rat IgG (Jackson Immuno-chemicals) at a dilution of 1:40 in BSS/5% NBS for 20 min on ice. Cells were washed and analyzed on a FACScan (Becton Dickinson, Mountain View, CA). Primary antibody staining was preceded by blocking of Fc receptors with nonspecific mouse IgG (Calbiochem Corp.). Cells stained with either streptavidin-phycoerythrin or FITC-conjugated mouse anti-rat IgG alone (without primary antibody) were used as controls for background staining. Flow cytometric analysis was carried out using a FACScan0 (Becton Dickinson) with an argon laser at 488 nm. Statistics. Statistical analysis was carried out using the Minitab program. Student's t test was used to compare the difference of survival time between different groups of mice. Chi square was used to test the difference in the frequency of mice with growth factor independent cells. The Mann-Whitney test was used to compare the difference between spleen weights in control and experimental animals.
Results
Development and characterization of Kit expressing cell lines. The overall purpose of our studies was to examine the growth of Kit expressing 32D cells in syngeneic animals. To do this it was first necessary to obtain factor dependent cell lines that differed only in their expression of c-Kit. The first cKit expressing cell line that we studied was 32DmKit(A4) which was isolated following retroviral infection of the c-Kit negative IL-3-dependent cell line 32D. Northern blot analysis revealed that 32DmKit(A4) cells and not 32D cells expressed large amounts of mKit RNA (Fig. 1 ). The presence of Kit protein on the cell surface was confirmed using biotinylated mKL or the anti-Kit antibody ACK-2 (Fig. 2) . The response to growth factors of 32DmKit(A4) cells was compared with the parental cell line. 32D cells grew well in mIL-3, however, the cells rapidly lost viability in the absence of mIL-3 or in the presence of mKL. In contrast 32DmKit(A4) cells grew in suspension in IL-3 or mKL (Table I ). The growth rate of 32DmKit(A4) cells in mKL was somewhat slower than in mIL-3 (data not shown) and a lower saturation density was reached (Table I) .
In a preliminary experiment 32D and 32DmKit(A4) cells were injected into lethally irradiated C3H/HeJ mice. 32DmKit(A4) cells, but not 32D cells resulted in the development of a leukemic state after 7 wk (data not shown).
The above results indicated that 32DmKit expressing cells could survive and proliferate in syngeneic animals. However, this could be explained by clonal variation possibly resulting from the site of integration of the retrovirus carrying the Kit cDNA. For this reason we generated the K series of Kit expressing lines by the electroporation of LXSNNot-mKit into 32D cells. Three independent cell lines, 32mKit(K2), 32mKit(K1O) and 32DmKit(K16) were selected for their ability to survive and grow in mKL or mIL-3; the cells died rapidly in the absence of growth factor.
Expression of Kit RNA and Kit protein. The amount of Kit RNA and protein was determined as part of the characterization of the cell lines. Northern blot analysis for Kit RNA revealed that there was a marked difference in the amount of message between the cell lines (Fig. 1) . The 32DmKit(A4) cells had the largest amount of message while 32DmKit(K1O) cells had the least. The variation in the amount of Kit message was reflected in the protein studies. The presence of cell surface Kit was determined by flow cytometry using either biotinylated mKL or ACK-2, an antibody directed against Kit (Fig. 2) . Kit cell surface expression was greatest on 32DmKit(A4) cells followed by 32DmKit(K2), 32DmKit(K16), and 32DmKit-(K1O) cells.
Injection that had been injected with 32Dneo cells were also killed at 7 and 150 d; at neither of these times was it possible to recover IL-3 responsive and/or G418 resistant cells. These results indicate that 32DmKit cells but not 32Dneo cells could persist in syngeneic animals. Development of leukemia in 32DmKit-injected animals. As mentioned above the animals were observed on a daily basis. Animals that had been injected with 32DmKit cells became progressively weak and moribund beginning at 6 wk after the start of the experiment. These animals were killed and their organs examined for evidence of infiltration by leukaemic cells (Table IV) .
A red blood cell count done at the time of death revealed that all of the animals injected with 32DmKit cells were anemic, whereas control animals had a normal red blood cell count. Peripheral blood analysis revealed a marked decrease in the number and frequency of normal mature lymphocytes and granulocytes and the presence of circulating blast cells (Fig. 3) . In the bone marrow the majority of the cells were blast cells.
Gross anatomic examination revealed that the spleen was enlarged in all animals injected with 32DmKit cells in comparison to normal animals (Table V) ; there was no correlation between the size of the spleen and the presence of factor independent clones or the degree of expression of Kit by the 32D cells. Histologic examination of the spleen demonstrated almost complete replacement of the spleen by 32DmKit cells. Infiltration by blast cells was also observed in the liver, lung, kidney, gut, and brain. Infiltration of the liver began in the periportal area and extended into the liver lobule (Fig. 3) . In some cases the liver architecture was totally disrupted. Infiltration of the brain was evident in two anatomic areas. Most frequently there was infiltration of the meninges, however in some cases there was also involvement of the white matter itself (Fig. 3) . The denominator is the number of mice at risk and the numerator is the number of mice demonstrating that characteristic. * PBB, peripheral blood blasts. A4(-), mice injected with 32DmKit(A4) cells were not irradiated. A4-250, mice injected with 32DmKit(A4) cells were irradiated to 250 cGy.
All other groups of animals received 900 cGy.
Involvement of the lung, kidney and gut was more variable among animals.
To determine whether cells isolated from leukemic animals maintained the ability to grow in syngeneic hosts, secondary transfers were performed. Factor-dependent and -independent cells isolated from diseased animals were transferred to irradiated syngeneic mice as described above. In either circumstance the cells engrafted and the animals became moribund. The time to developing signs of failure to thrive was similar to that for animals receiving 32DKit(A4) cells.
Development of factor independent growth. Some of the animals, studied 3 wk after injection, harboured 32DmKit cells that did not require added mIL-3 or mKL for survival and proliferation. The presence of factor-dependent and -independent cell lines in bone marrow and spleen at the time the animals became moribund was assessed in a manner identical to that at 3 wks. The proportion of animals containing factor independent cells was greater at the later time point (Table EI) . There was no correlation between the development of factor independence and the involvement of specific tissues in the mice nor the time to becoming moribund. KLL- Figure 4 . Northern blot of RNA from the stromal cell lines S1O and S1/S14 probed for the expression of KL. Equivalent loading was determined using ethidium bromide staining (data not shown).
Role of irradiation. The majority of animals used in these studies received lethal irradiation. This was done in order to allow rapid engraftment of the 32Dmkit cells. However it is also possible that the irradiation was immunosuppressive, which then aided the growth of the 32DmKit cells. To test this, animals were prepared with no or sublethal irradiation and no added normal cells. In all cases there was the development of leukemia; however, the time to death was longer in the animals that received only 250 cGy or no irradiation (Table VI) .
Growth on bone marrow stroma cell lines. The above experiments demonstrate that cells expressing Kit and dependent on the presence of mKL or mIL-3 for growth and survival, can proliferate in syngeneic animals. The most likely explanation for this is that the cells are being stimulated by KL expressed by endogenous mouse cells. An appropriate negative control for this would be to inject animals deficient in KL with 32DmKit cells. Unfortunately animals lacking KL are not viable (41), however stromal cell lines have been developed from such animals at the fetal stage of development. We compared the growth of 322mKit(A4) cells on S1/S14 cells and on S10 bone marrow stromal cells. The SI/S 14 cells do not express any KL message while S 10 cells produce abundant amounts of KL message (Fig.  4) . The 
Discussion
The growth of human leukaemic cells in tissue culture is dependent upon the presence of specific growth factors (1, 2, 7, 24, 42, 43) . This has led to the suggestion that the growth in vivo is also dependent upon the presence of growth factors. A number of models have been proposed for the presentation of growth factors in vivo. These include models by which the leukemic cells produce the growth factors that they respond to (an autocrine model) (44, 45) or host cells such as macrophages and stromal cells produce the required growth factors (paracrine model) (9) . The autocrine hypothesis is supported by an animal model in which a GM-CSF/IL-3-dependent murine cell line was genetically engineered to produce GM-CSF (46) . The parental cells were unable to grow in syngeneic animals while the modified cell line was able to grow and kill the animals (46) . In addition to illustrating the potential for autocrine growth of leukemic cells this experiment demonstrated that in normal animals that there are insufficient levels of GM-CSF or IL-3 to support the growth of the cells (46, 47) .
The paracrine model can take two forms. In one case the leukaemic cells may produce factors that stimulate the neighboring cells to make growth factors to which the leukemic cells can then respond. For example some human leukaemic cells have been found to produce IL-I which may then induce stromal cells to produce high levels of GM-CSF, G-CSF, and M-CSF (48) ; these are all factors required for the growth of some leukaemic cells (7, 9, (49) (50) (51) (52) (53) (54) (55) (56) . This model requires that the leukaemic cells aberrantly express a cytokine and express a receptor for the induced growth factor. To date there has not been any in vivo evidence for this model.
Another form of the paracrine model requires leukemic cells to express a receptor for a growth factor which is constitutively expressed in the normal animal. The experiments presented in this paper support this model.
The initial publication characterizing 32D cells described a cell line that required IL-3 for growth in culture and could not grow in syngeneic animals (25 (18, 19, 57) . The in vivo studies also demonstrates that there is insufficient IL-3 produced in the animal to maintain the viability of 32Dneo or 32DmKit cells.
The cell lines used in our studies varied in their ability to proliferate in vitro and in vivo. 32DmKit(A4) cells grew most rapidly and to a higher saturation density in culture than the other cell lines. These differences were further reflected by the time required for the animals to become moribund. Animals injected with 32DmKit(A4) cells became ill sooner than animals that had been injected with other cell lines. A possible explanation for the difference in behaviour of the cell lines is that the cells expressed different amounts of mKit on their surface. Both the ligand binding studies and the studies with the anti-Kit antibody, ACK-2, showed variations between the cell lines. 32mKit(A4) cells had the highest expression followed in order by 32DmKit(K2), 32DmKit(Ki6) and 32DmKit(KIO). A correlation was found between the level of expression of mKit and the time to the development of leukemia, with high mKit expressers developing leukemia more rapidly.
Another feature of the 32D mKit expressing cells was the development of factor-independent cells during in vivo culture. In tissue culture we had not observed any factor independent cells in more than 1 x 108 32D, 32DmKit, or 32Dneo cells. Yet factor independent cells arose at a high frequency in vivo, in the mKit expressing cells. This was most evident in the cells that expressed low levels of mKit where cells from 3 of 6 animals at 3 wk and 6 of 6 animals at the time the animals were moribund were factor independent. This is in contrast to the cell lines expressing higher levels of mKit in which 0 of 6 animals at three weeks and 5 of 9 animals at the time the animals were moribund, contained factor-independent cells. The molecular events responsible for factor independence are not known. We were unable to detect IL-3 or KL in conditioned medium or the presence of IL-3 or KL transcripts in RNA from any of the cell lines. The cell lines that we have developed will be useful in determining mechanisms by which cells become factor independent. The role that mKit and mKit ligand play in the development of factor independent leukemic cells is un 
